HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease

Frontiers in Bioscience

Volumn 13, Issue 18, 2008, Pages 7072-7086

  Mizuno, Shinya ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Extracellular Matrix; HGF; Met; MMP; Myofibroblasts; Renal Fibrosis; Review; TGF beta

Indexed keywords

MUS;

PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; CHRONIC KIDNEY FAILURE; DRUG ANTAGONISM; FIBROSIS; FOCAL GLOMERULOSCLEROSIS; GENE THERAPY; GENETICS; HUMAN; KIDNEY TUBULE; METHODOLOGY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; FIBROSIS; GENE THERAPY; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; MICE; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-MET; TRANSFORMING GROWTH FACTOR BETA1;

EID: 52049123764     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3211     Document Type: Article

References (125)

1. A. Ong and L. G. Fine: Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int 45, 345-351 (1994) (Pubitemid 24065065)
2. N. A. Noble and W. A. Border: Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 17, 455-466 (1997) (Pubitemid 27398458)
3. G. Wolf: Renal injury due to renin-angiotensinaldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70, 1914-1919 (2006) (Pubitemid 44863378)
4. C. Chatziantoniou and J. C. Dussaule: Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289, F227-F234 (2005) (Pubitemid 41003650)
5. K. Matsumoto and T. Nakamura: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119, 591-600 (1996) (Pubitemid 26131762)
6. H. Funakoshi and T. Nakamura: Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327, 1-23 (2003) (Pubitemid 35447813)
7. C. Birchmeier, W. Birchmeier, E. Gherardi and G. F. Vande Woude: Met, metastasis, motility and more. Nature Rev Mol Cell Biol 4, 915-925 (2003) (Pubitemid 37493640)
8. K. Matsumoto and T. Nakamura: Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 59, 2023-2038 (2001) (Pubitemid 32467594)
9. Y. Liu: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 11, 23-30 (2002) (Pubitemid 34053334)
10. D. F. Balkovetz and J. H. Lipschutz: Hepatocyte growth factor and the kidney: it is not just for the liver. Int Rev Cytol 186, 225-260 (1999) (Pubitemid 129751082)
11. S. Mizuno, T. Kurosawa, K. Matsumoto, Y. Mizuno-Horikawa, M. Okamoto and T. Nakamura: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101, 1827-1834 (1998) (Pubitemid 28226100)
12. S. Mizuno and T. Nakamura: Chapter 13. Hepatocyte growth factor: Physiological and therapeutic ligand to attenuate diabetic nephropathy. -Diabetic Kidney. pp225-253 Humana Press, Totawa (2006)
13. Y. Liu Y: Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 287, F7-16 (2004)
14. T. Nakamura, K. Nawa and A. Ichihara: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122, 1450-1459 (1984) (Pubitemid 14073577)
15. T. Nakamura, T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro and S. Shimizu: Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443 (1989) (Pubitemid 19277521)
16. K. Miyazawa, H. Tsubouchi, D. Naka, K. Takahashi, M. Okigaki, N. Arakaki, H. Nakayama, S. Hirono, O. Sakiyama, K. Takahashi, E. Gohda, Y. Daikuhara, and N. Kitamura: Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor, Biochem Biophys Res Commun 163, 967-973 (1989) (Pubitemid 19236944)
17. T. Igawa, S. Kanda, H. Kanetake, Y. Saitoh, A. Ichihara, Y. Tomita and T. Nakamura: Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 174, 831-838 (1991)
18. R. Montesano, K. Matsumoto, T. Nakamura and L. Orci: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908 (1991) (Pubitemid 121001504)
19. K. Matsumoto, S. Mizuno S and T. Nakamura: Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens 9, 395-402 (2000) (Pubitemid 30451695)
20. Y. Yo, R. Morishita, S. Nakamura, N. Tomita, K. Yamamoto, A. Moriguchi, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int 54, 1128-1138 (1998) (Pubitemid 28449899)
21. Y. Liu, A. M. Sun and L. D. Dworkin: Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 246, 821-826 (1998) (Pubitemid 28420942)
22. T. Igawa, K. Matsumoto, S. Kanda, Y. Saito and T. Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol Renal Physiol 265, F61-F69 (1993) (Pubitemid 23221552)
23. K. Kawaida, K. Matsumoto, H. Shimazu and T. Nakamura: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91, 4357-4361 (1994) (Pubitemid 24143432)
24. S. B. Miller, D. R. Martin, J. Kissane and M. R. Hammerman: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol Renal Physiol 266, F129-F134 (1994)
25. M. S. Pepper, K. Matsumoto, T. Nakamura, L. Orci and R. Montesano: Hepatocyte growth factor induces urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in MDCK epithelial cells. J Biol Chem 267, 20493-20496 (1992)
26. K. Ishibashi, S. Sasaki, H. Sakamoto, Y. Nakamura, T. Hata, T. Nakamura and F. Marumo: Hepatocyte growth factor is a paracrine factor for renal epithelial cells: Stimulation of DNA synthesis and Na,K-ATPase activity. Biochem Biophys Res Commun 182, 960-965 (1992)
27. Y. Yo, R. Morishita, K. Yamamoto, N. Tomita, I. Kida, S. Hayashi, A. Moriguchi, M. Aoki, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kindney Int 53, 0-58 (1998)
28. M. Kolatsi-Joannou, A. S. Woolf, P. Hardman, S. J. White, M. Gordge and R. M. Henderson: The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. J Cell Sci 108, 3703-3714 (1995) (Pubitemid 26003204)
29. H. Li, T. Jiang, Y. Lin, Z. Zhao and N. Zhang: HGF protects rat mesangial cells from high-glucose-mediated oxidative stress. Am J Nephrol 26, 519-530 (2006) (Pubitemid 44971745)
30. N. Radhakrishnan, M. Bhaskaran and P. C. Singhal: HGF modulates H2O2-induced mesangial cell apoptosis through induction of heme oxygenase-1. Nephron Physiol 101, 92-98 (2005)
31. A. Fornoni, H. Li, A. Foschi, G. E. Striker and L. J. Striker: Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 158, 275-280 (2001) (Pubitemid 32096493)
32. T. Mori, A. Shimizu, Y. Masuda, Y. Fukuda and N. Yamanaka: Hepatocyte growth factor stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis. Nephron Exp Nephrol 94, 44-54 (2003)
33. C. Birchmeier and E. Gherardi: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8, 404-410 (1998) (Pubitemid 28458706)
34. A. S. Woolf, M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble and E. Gherardi: Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol 128, 171-184 (1995)
35. O. F. Santos, E. J. Barros, X. M. Yang, K. Matsumoto, T. Nakamura, M. Park and S. K. Nigam: Involvement of hepatocyte growth factor in kidneny development. Dev Biol 163, 525-529 (1994) (Pubitemid 24221635)
36. S. Aoki, K. Takahashi, K. Matsumoto and T. Nakamura: Activation of Met tyrosine kinase by hepatocyte growth factor is essential for internal organogenesis in Xenopus embryo. Biochem Biophys Res Commun 234, 8-14 (1997) (Pubitemid 27267521)
37. B. W. Snow, W. F. Tarry and J. W. Duckett: Compensatory renal growth: interactions of nephrectomy serum and urine antisera leading to a new theory of renal growth regulation. Urol Res 15, 1-4 (1987) (Pubitemid 17013487)
38. M. Nagaike, S. Hirao, H. Tajima, S. Noji, S. Taniguchi, K. Matsumoto and T. Nakamura: Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 266, 22781-22784 (1991) (Pubitemid 21908716)
39. S. Kono, M. Nagaike, K. Matsumoto and T. Nakamura: Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 186, 991-998 (1992)
40. S. Mizuno and T. Nakamura: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 166, 1895-1905 (2005) (Pubitemid 40734411)
41. H. Ohnishi, S. Mizuno and T. Nakamura: Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure. Am J Physiol Renal Physiol 294, F326-F335 (2008) (Pubitemid 351199397)
42. K. Matsumoto and T. Nakamura: Hepatocyte growth factor as a renotropic factor and therapeutic potential for acute renal failure. -Acute Renal Failure: Emerging New Concepts and Therapeutic Strategies (M.S. Goligorosky, ed) Churchill: Livingstone, p450-p474 (1995)
43. K. Sugimura, T. Kim, T. Goto, S. Kasai, Y. Takemoto, J Matsuda, M. Yoshimoto, S. Yamagami and T. Kishimoto: Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron 70, 324-328 (1995)
44. E. Randers, E. J. Erlandsen, J. H, Kristensen, S. Markussen, O. L. Pedersen, H. Danielsen and P. E. Jorgensen: Serum hepatocyte growth factor levels in patients with chronic renal disease-effect of GFR and pathogenesis. Scand J Clin Lab Invest 61, 615-619 (2001) (Pubitemid 33105068)
45. M. Nishida, H. Kawakatsu, K. Ishiwari, M. Tamai, T. Sawada, M. Nishimura and M. Yoshimura: Serum hepatocyte growth factor levels in patients with renal diseases. Am J Nephrol 19, 509-512 (1999) (Pubitemid 29397083)
46. S. Takada, M. Namiki, S. Takahara, K. Matsumiya, N. Kondoh, Y. Kokado, K. Matsumoto, T. Nakamura and A. Okuyama: Serum HGF levels in acute renal rejection after living related renal transplantation. Transpl Int 9, 151-154 (1996) (Pubitemid 26054196)
47. K. Sugimura, C. C. Lee, T. Kim, T. Goto, S. Kasai, K. Harimoto, S. Yamagami and K. Kishimoto: Production of hepatocyte growth factor is increased in chronic renal failure. Nephron 75, 7-12 (1997) (Pubitemid 27052930)
48. N. Nakano, A. Moriguchi, R. Morishita, I. Kida, N. Tomita, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. Hypertension 30:1448-1454 (1997) (Pubitemid 27528088)
49. H. H. Parving: Initiation and progression of diabetic nephropathy. N Engl J Med 335, 1682-1683 (1996)
50. M. Essawy, O. Soylemezoglu, E. C, Muchaneta-Kubara, J. Shortland, C. B. Brown and A. M. el Nahas: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12, 43-50 (1997) (Pubitemid 27046200)
51. F, N. Ziyadeh, B. B. Hoffman, C. C. Han, M. C. Iglesias-Cruz, S. W. Hong, M. Isono, S. Chen, T. A. McGowan and K. Sharma: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97, 8015-8020 (2000) (Pubitemid 30460765)
52. S. Goldfar and F. N. Ziyadeh: TGF-β: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc 112, 27-32 (2001)
53. S. Nakamura, R. Morishita, A. Moriguchi, Y. Yo, Y. Nakamura, S. Hayashi, K. Matsumoto, T. Nakamura, J. Higaki and Ogihara T: Hepatocyte growth factor as a potential index of complication in diabetes mellitus. J Hypertensions 16, 2019-2026 (1998) (Pubitemid 29002383)
54. B. Kulseng, M. Borset, T. Espevik and A. Sundan: Elevated hepatocyte growth factor in sera from patients with insulin-dependent diabetes mellitus. Acta Diabetol 35: 77-80 (1998) (Pubitemid 28403236)
55. Y. Liu, E. M. Tolbert, A. M. Sun and L. D. Dworkin: In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat. Am J Physiol Renal Physiol 271, F1202-F1210 (1996)
56. R. Morishita, S. Nakamura, Y. Nakamura, M. Aoki, A. Moriguchi, I. Kida, Y. Yo, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Potential role of an endothelium-specific growth factor, hepatocyte rowthfactor, on endothelial damage in diabetes. Diabetes 46, 138-142 (1997) (Pubitemid 27009962)
57. S. Mizuno and T. Nakamura: Suppressions of chronic glomerular injuries and TGF-beta1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 286, F134-F143 (2004) (Pubitemid 38045051)
58. N. Nakano, R. Morishita, A. Moriguchi, Y. Nakamura, S. I. Hayashi, M. Aoki, I. Kida, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension 32, 444-451 (1998) (Pubitemid 28429132)
59. K. Matsumoto, H. Tajima, H. Okazaki and T. Nakamura T: Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta1 and glucocorticoids. J Biol Chem 267, 24917-24920 (1992)
60. R. A. Risdon, J. C. Sloper and W. H. Wardener: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2, 363-366 (1968)
61. A. Bohle, F. Strutz and G. A. Muller: On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol 2, 205-210 (1994) (Pubitemid 24201686)
62. S. Mizuno, B. F. Yue, M. Okamoto, Y. Horikawa and T. Kurosawa: Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 5, 498-507 (1997) (Pubitemid 28044471)
63. S. Mizuno, K. Matsumoto, T. Kurosawa, Y. Mizuno-Horikawa and T. Nakamura: Reciprocal balance of hepatocyte growth factor and transforming growth factorbeta1 in renal fibrosis in mice. Kidney Int 57, 937-948 (2000) (Pubitemid 30434784)
64. S. Mizuno, K. Matsumoto and T. Nakamura: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59, 1304-1314 (2001) (Pubitemid 32281218)
65. S. Klahr and J. Morrissey: Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int (Suppl), S105-S112 (2003) (Pubitemid 37315516)
66. X. Gao, H. Mae, N. Ayabe, T. Takai, K. Oshima, M. Hattori, T. Ueki, J. Fujimoto and T. Tanizawa: Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 62, 1238-1248 (2002)
67. Y. Liu, K. Rajur, E. Tolbert and L. D. Dworkin: Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58, 2028-2043 (2000)
68. R. Gong, A. Rifai, E. M. Tolbert, P. Biswas, J. N. Centracchio and L. D. Dworkin: Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J Am Soc Nephrol 15, 2868-2881 (2004) (Pubitemid 41103396)
69. Gong, A. Rifai and L. D. Dworkin: Antiinflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. J Am Soc Nephrol 17, 2464-2473 (2006) (Pubitemid 44300962)
70. H. Takayama, W. J. LaRochelle, S. G. Sabnis, T. Otsuka and G. Merlino: Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 77, 131-138 (1997) (Pubitemid 27355909)
71. M. Mazzone, C. Basilico, S. Cavassa, S. Pennacchietti, M. Risio, L. Naldini, P. M. Comoglio and P. Michieli: An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest 114, 1418-1432 (2004) (Pubitemid 40385573)
72. K. Miyazawa, T. Shimomura, and N. Kitamura: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271, 3615-3618 (1996) (Pubitemid 26065675)
73. T. Kunisada, H. Yamazaki, T. Hirobe, S. Kamei, M. Omoteno, H. Tagaya, H. Hemmi, U. Koshimizu, T. Nakamura and S. I. Hayashi: Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech Dev 94, 67-78 (2000) (Pubitemid 30332389)
74. A. M. Gressner: The cell biology of liver fibrogenesis: an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 292, 447-452 (1998) (Pubitemid 28282456)
75. A. M. Nahas, E. C. Muchaneta-Kubara, M. Essawy and O. Soylemezoglu: Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol 29: 55-62 (1997) (Pubitemid 27096419)
76. R. J. Johnson, E. W. Raines, J. Floege, A. Yoshimura, P. Pritzl, C. Alpers and R. Ross: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416 (1992)
77. W. A. Border, S. Okuda, L. R. Languino, M. B. Sporn and E. Ruoslahti: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-beta1. Nature 346: 371-374 (1990)
78. Y. Isaka, Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada and E. Imai: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or plateletderived growth factor gene into the rat kidney. J Clin Invest 92, 2597-2601 (1993) (Pubitemid 24006522)
79. K. Bessho, S. Mizuno, K. Matsumoto and T. Nakamura: Counteractive effects of HGF on PDGFinduced mesangial cell proliferation in a rat model of glomerulonephritis. Am J Physiol Renal Physiol 284, F1171-F1180 (2003) (Pubitemid 36578444)
80. W. H. Kim, K. Matsumoto, K. Bessho and T. Nakamura: Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166, 1017-1028 (2005) (Pubitemid 40524427)
81. M. Ono, Y. Sawa, S. Mizuno, N. Fukushima, H. Ichikawa, K. Bessho, T. Nakamura and H. Matsuda: Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation 110, 2896-2902 (2004) (Pubitemid 39473615)
82. W. A. Border and N. A. Noble: Transforming growth factor-beta in tissue fibrosis. N Engl J Med 331, 1286-1292 (1994) (Pubitemid 24333194)
83. S. Kagami, W. A. Border, D. E. Miller and N. A. Noble: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93, 2431-2437 (1994) (Pubitemid 24177156)
84. H. Peters, W. A. Border and N. A. Noble: Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54, 1570-1580 (1998) (Pubitemid 28502899)
85. J. Gaedeke, H. Peters, N. A. Noble and W. A, Border: Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol 135, 153-160 (2001) (Pubitemid 33352377)
86. T. Nakamura, K. Matsumoto, S. Mizuno, Y. Sawa, H. Matsuda and T. Nakamura: Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol 288, H2131-H2139 (2005) (Pubitemid 40604097)
87. S. L. Zhang, C. To, X. Chen, J. G. Filep, S. S. Tang, J. R. Ingelfinger and J. S. Chan: Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol 13, 302-312 (2002) (Pubitemid 34106271)
88. C. Dai and Y. Liu: Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 15, 1402-1412 (2004) (Pubitemid 38679665)
89. J. Yang and Y. Liu: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13, 96-107 (2002) (Pubitemid 34042016)
90. E. Kobayashi, H. Sasamura, M. Mifune, R. Shimizu-Hirota, M. Kuroda, M. Hayashi and T. Saruta: Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts. Kidney Int 64, 1179-1188 (2003) (Pubitemid 37153782)
91. T. Inoue, H. Okada, T. Kobayashi, Y. Watanabe, Y. Kanno, J. B. Kopp, T. Nishida, M. Takigawa, M. Ueno, T. Nakamura and H. Suzuki: Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6-nephrectomized mice. FASEB J 17, 268-270 (2003)
92. I. Ozaki, G. Zhao, T. Mizuta, Y. Ogawa, T. Hara, S. Kajihara, A. Hisatomi, T. Sakai and K. Yamamoto. HGF induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 36, 169-178 (2002) (Pubitemid 34146423)
93. Y. Matsuda, K. Matsumoto, T. Ichida and T. Nakamura: Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 118, 643-649 (1995)
94. Y. Taniyama, R. Morishita, H. Nakagami, A. Moriguchi, H. Sakonjo, S. Kim, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Potential contribution of a novel anti-fibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102, 246-252 (2000) (Pubitemid 30451784)
95. S. Mizuno, K. Matsumoto, M. Y. Li and T. Nakamura: HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. FASEB J 19, 580-582 (2005) (Pubitemid 40471250)
96. S. M. Frisch, K. Vuori, E. Ruoslahti and P. Y. Chan-Hui: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134, 793-799 (1996) (Pubitemid 26269148)
97. J. P. Iredale, R. C. Benyon, J. Pickering, M. McCullen, M. Northrop, S. Pawley C. Hovell and M. J. Arthur: Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102, 538-549 (1998) (Pubitemid 28376157)
98. M. C. Wright, R. Issa, D. E. Smart, N. Trim, G. I. Murray, J. N. Primrose, M. J. Arthur, J. P. Iredale and D. A. Mann: Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685-698 (2001) (Pubitemid 32822584)
99. A. J. Baker, A. Mooney, J. Hughes, D. Lombardi, R. J. Johnson and J. Savill: Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94, 2105-2116 (1994) (Pubitemid 24348252)
100. A, Desmouliere, M. Redard, I. Darby and G. Gabbiani: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146, 56-66 (1995)
101. J. Yang and Y. Liu: Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 284, F349-F357 (2003) (Pubitemid 36114697)
102. I. Herrero-Fresneda, J. Torras, M. Franquesa, A. Vidal, J. M. Cruzado, N. Lloberas, C. Fillat and J. M. Grinyo: HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatoryinduced mechanisms. Kidney Int 70, 265-274 (2006) (Pubitemid 44086576)
103. J. M. Cruzado, N. Lloberas, J. Torras, M. Riera, C. Fillat, I. Herrero-Fresneda, J. M. Aran, G. Alperovich, A. Vidal and J. M. Grinyo: Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 53, 1119-1127 (2004) (Pubitemid 38436627)
104. Y. Kawasaki, T. Imaizumi, H. Matsuura, S. Ohara, K. Takano, K. Suyama, K. Hashimoto, R. Nozawa, H. Suzuki and M. Hosoya: Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2008, in press
105. H. Azuma, S. Takahara, K. Matsumoto, N. Ichimaru, J. D. Wang, T. Moriyama, A. M. Waaga, M. Kitamura, Y. Otsuki, A. Okuyama, Y. Katsuoka, A. Chandraker, M. H. Sayegh and T. Nakamura: Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12, 1280-1292 (2001) (Pubitemid 32472643)
106. R. Gong, A. Rifai and L. D. Dworkin: Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells. Biochem Biophys Res Commun 330: 27-33 (2005) (Pubitemid 40394931)
107. R. Gong, A. Rifai, Y. Ge, S. Chen and L. D. Dworkin: Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3-beta inactivation in renal tubular epithelial cells. J Biol Chem 283: 7401-7410 (2008)
108. Y. Isaka, K. Yamada, Y. Takabatake, M. Mizui, M. Miura-Tsujie, N. Ichimaru, K. Yazawa, R. Utsugi, A. Okuyama, M. Hori, E. Imai and S. Takahara: Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Ther 12, 815-820 (2005) (Pubitemid 40753973)
109. B. M. Brenner, T. W. Meyer and T. H. Hostetter: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307, 652-659 (1982) (Pubitemid 12049914)
110. C. Dai, J. Yang, S. Bastacky, J. Xia, Y. Li and Y. Liu: Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 15, 2637-2647 (2004) (Pubitemid 41103370)
111. T. Kagawa, G. Takemura, K. Kosai, I. Murata, T. Ohno, T. Takahashi, M. Esaki, R. Maruyama, T. Fujiwara, H. Ohashi and H. Fujiwara: Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice. Nephron Physiol 102, 92-102 (2006)
112. S. Ishidoya, J. Morrissey, R. McCracken and S. Klahr: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49, 1110-1119 (1996) (Pubitemid 26122714)
113. K. Matsumoto, R. Morishita, A. Moriguchi, N. Tomita, Y. Yo, T. Nishii, T. Nakamura, J. Higaki and T. Ogihara: Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Hypertension 34, 279-284 (1999) (Pubitemid 29409228)
114. J. Yang, C. Dai and Y. Liu. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13, 2464-2477 (2002)
115. S. Mizuno and T. Nakamura: Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2, 161-170 (2007) (Pubitemid 46831077)
116. Y. Li, B. C. Spataro, J. Yang, C. Dai and Y. Liu: 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int 68, 1500-1510 (2005) (Pubitemid 43173380)
117. Y. Li, X. Wen, B. C. Spataro, K. Hu, C. Dai and Y. Liu: Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferatoractivated receptor-gamma agonists. J Am Soc Nephrol 17, 54-65 (2006)
118. M. H. Wu, H. Yokozeki, S. Takagawa, T. Yamamoto, T. Satoh, Y. Kaneda, I. Katayama and K. Nishioka: Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma. Gene Ther 11, 170-180 (2004) (Pubitemid 38159689)
119. F. Nayeri, T. Stromberg, M. Larsson, L. Brudin, C. Soderstrom and P. Forsberg: Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. J Dermatol Treat 13, 81-86 (2002) (Pubitemid 34670366)
120. G. Marino, V. K. Rustgi, G. Salzberg, L. B. Johnson, P. C. Kuo, J. S. Plotkin and D. A. Flockhart: Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease. Aliment Pharmacol Ther 16, 235-242 (2002) (Pubitemid 34146364)
121. R. Morishita, M. Aoki, N. Hayashi, H. Makino, K. Yamasaki, J. Azuma, Y. Sawa, H. Matsuda, Y. Kaneda and T. Ogihara: Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44, 203-209 (2004) (Pubitemid 39014240)
122. M. Mizui, Y. Isaka, Y. Takabatake, S. Mizuno, T. Nakamura, T. Ito, E. Imai and M. Hori: Electroporationmediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 65, 2041-2053 (2004) (Pubitemid 38669990)
123. K. Yazawa, Y. Isaka, S. Takahara, E. Imai, N. Ichimaru, Y. Shi, Y. Namba and A. Okuyama: Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Nephrol Dial Transplant 19, 812-816 (2004) (Pubitemid 38455650)
124. H. Okada, Y. Watanabe, T. Inoue, T. Kobayashi, Y. Kanno, G. Shiota, T. Nakamura, T. Sugaya, A. Fukamizu and H. Suzuki: Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant 18, 2515-2523 (2003) (Pubitemid 37483784)
125. T. Tanaka, N. Ichimaru, S. Takahara, K. Yazawa, M. Hatori, K. Suzuki, Y. Isaka, T. Moriyama, E. Imai, H. Azuma, T. Nakamura, A. Okuyama and H. Yamanaka: In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy. Am J Transplant 2, 828-836 (2002) (Pubitemid 36306837)